Health.Zone Web Search

  1. Ad

    related to: dmg health pharmaceuticals stock news

Search results

  1. Results from the Health.Zone Content Network
  2. Danaher Corporation - Wikipedia

    en.wikipedia.org/wiki/Danaher_Corporation

    History Early years. The company's origins go back to a Massachusetts real estate investment trust organized in 1969 as DMG, Inc. In 1978, DMG, Inc. was reorganized as a Florida corporation and changed its name to Diversified Mortgage Investors, Inc. DMG had been invested in retirement home developments when it was taken over by the Rales, and in 1984, the company adopted the name Danaher and ...

  3. Amgen jumps after teasing weight-loss drug data, rival stocks ...

    www.aol.com/news/amgen-shares-jump-teasing...

    The company's stock is trading 13.9 times its forward 12-month earnings estimates, compared with a forward price-to-earnings ratio of 34.2 for Novo Nordisk and 48.49 for Eli Lilly.

  4. Catamaran Corporation - Wikipedia

    en.wikipedia.org/wiki/Catamaran_Corporation

    Catamaran Corporation (formerly SXC Health Solutions) is the former name of a company that now operates within UnitedHealth Group's OptumRX division (since July 2015). It sells pharmacy benefit management and medical record keeping services to businesses in the United States [3] and to a broad client portfolio, including health plans and ...

  5. Cassava Sciences - Wikipedia

    en.wikipedia.org/wiki/Cassava_Sciences

    www .cassavasciences .com. Cassava Sciences is an American pharmaceutical company based in Austin, Texas. The company was founded in 1998 by chief executive officer and president Remi Barbier as Pain Therapeutics, Inc., changing its name in 2019. Cassava is developing simufilam (previously known as PTI-125 and sumifilam), an oral-tablet drug ...

  6. Amgen investors await weight-loss drug data - AOL

    www.aol.com/news/amgen-investors-await-weight...

    Both have become among the world's most valuable publicly traded companies due to explosive demand for their weight-loss drugs. For the first quarter, analysts expect Amgen to report earnings of ...

  7. FDA Approves New Drug for Macular Degeneration - Healthline

    www.healthline.com/health-news/fda-approves-new...

    The Food and Drug Administration (FDA) has approved a new drug for treating two conditions that cause vision loss. The drug Vabysmo (faricimab-svoa) treats wet age-related macular degeneration ...

  8. Assertio Therapeutics - Wikipedia

    en.wikipedia.org/wiki/Assertio_Therapeutics

    Assertio Therapeutics, Inc. (formerly Depomed, Inc.) is an American specialty pharmaceutical company. [3] It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. [4] Depomed was founded in 1995 and is headquartered in Newark, California. [5] It is a publicly traded company on NASDAQ, with several ...

  9. Bausch Health - Wikipedia

    en.wikipedia.org/wiki/Bausch_Health

    Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.) is an American-Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs , primarily for skin diseases , gastrointestinal disorders , eye health ...

  1. Ad

    related to: dmg health pharmaceuticals stock news